{
  "id": "33d11136e6a5fe5b",
  "title": "STAT+: Pharmalittle: We\u2019re reading about FDA approval for a novel antibiotic, setbacks at Sanofi, and much more",
  "description": "Sanofi flagged a second delay to an FDA decision for its experimental multiple sclerosis drug and reported disappointing results from a late-stage study",
  "content": "Sanofi flagged a second delay to an FDA decision for its experimental multiple sclerosis drug and reported disappointing results from a late-stage study",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2025/12/15/sanofi-fda-antibiotics-gonorrhea-novo-weight-hikma/?utm_campaign=rss",
  "published_at": "2025-12-15T14:25:53+00:00",
  "fetched_at": "2025-12-16T00:23:22.810654+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "antibiotic",
    "fda",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about FDA approval for a novel antibiotic, setbacks at Sanofi, and much more",
    "description": "Sanofi flagged a second delay to an FDA decision for its experimental multiple sclerosis drug and reported disappointing results from a late-stage study",
    "url": "https://www.statnews.com/pharmalot/2025/12/15/sanofi-fda-antibiotics-gonorrhea-novo-weight-hikma/?utm_campaign=rss",
    "published": "2025-12-15T14:25:53+00:00",
    "source": "STAT"
  }
}